PE20091531A1 - DERIVADOS DE N-HETEROCICLICO-6-HETEROCICLICO-IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA COMO MODULADORES DE LOS RECEPTORES NURR-1 - Google Patents
DERIVADOS DE N-HETEROCICLICO-6-HETEROCICLICO-IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA COMO MODULADORES DE LOS RECEPTORES NURR-1Info
- Publication number
- PE20091531A1 PE20091531A1 PE2008002194A PE2008002194A PE20091531A1 PE 20091531 A1 PE20091531 A1 PE 20091531A1 PE 2008002194 A PE2008002194 A PE 2008002194A PE 2008002194 A PE2008002194 A PE 2008002194A PE 20091531 A1 PE20091531 A1 PE 20091531A1
- Authority
- PE
- Peru
- Prior art keywords
- imidazo
- pyridine
- heterociclico
- alcoxy
- alkyl
- Prior art date
Links
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- BEHYAANJUKYBTH-UHFFFAOYSA-N imidazo[1,2-a]pyridine-2-carboxamide Chemical compound C1=CC=CC2=NC(C(=O)N)=CN21 BEHYAANJUKYBTH-UHFFFAOYSA-N 0.000 abstract 3
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 abstract 2
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 101000785650 Homo sapiens Zinc finger protein 268 Proteins 0.000 abstract 1
- -1 NOT Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 abstract 1
- 101001109694 Rattus norvegicus Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 abstract 1
- 102100026516 Zinc finger protein 268 Human genes 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000000626 neurodegenerative effect Effects 0.000 abstract 1
- 108020004017 nuclear receptors Proteins 0.000 abstract 1
- 102000006255 nuclear receptors Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A DERIVADOS DE IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDAS, DE FORMULA (I), DONDE X ES HETEROCICLO SUSTITUIDO OPCIONALMENTE CON HALOGENO, ALCOXI(C1-C6), ALQUILO(C1-C6), ENTRE OTROS; R1 ES H, HALOGENO, ALCOXI(C1-C6), ENTRE OTROS; R2 ES HETEROCICLO SUSTITUIDO OPCIONALMENTE CON HIDROXI, ALQUILO(C1-C6), ALCOXI(C1-C6), ENTRE OTROS; R3 ES H, ALQUILO(C1-C6), ALCOXI(C1-C4) O HALOGENO; R4 ES H ,ALQUILO(C1-C4), ALCOXI(C1-C4) O FLUOR. SON COMPUESTOS PREFERIDOS: 6-(1H-IMIDAZOL-4-IL)-N-(1,3-TIAZOL-2-IL)IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA, N-(PIRIDIN-2IL)-6-(1H-1,2,3-TRIAZOL-4-IL)IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA, N-(TIOFEN-3-IL)-6-(1H-1,2,3-TRIAZOL-4-IL)IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN METODO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA. DICHO COMPUESTO TIENE ACTIVIDAD SOBRE LOS RECEPTORES NUCLEARES NURR-1, TAMBIEN DENOMINADOS NR4A2, NOT, TINUR, RNR-1 Y HZF3, SIENDO DE UTILIDAD EN EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS, INFLAMATORIAS Y CANCER
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800006A FR2925904B1 (fr) | 2008-01-02 | 2008-01-02 | DERIVES DE N-HETEROCYCLIQUE-6-HETEROCYCLIQUE-IMIDAZO°1,2-a! PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091531A1 true PE20091531A1 (es) | 2009-10-29 |
Family
ID=39768560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008002194A PE20091531A1 (es) | 2008-01-02 | 2008-12-30 | DERIVADOS DE N-HETEROCICLICO-6-HETEROCICLICO-IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA COMO MODULADORES DE LOS RECEPTORES NURR-1 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20100317686A1 (es) |
| EP (1) | EP2225243B1 (es) |
| JP (1) | JP2011508762A (es) |
| KR (1) | KR20100103660A (es) |
| CN (1) | CN101959885A (es) |
| AR (1) | AR070075A1 (es) |
| AT (1) | ATE533767T1 (es) |
| AU (1) | AU2008351929A1 (es) |
| BR (1) | BRPI0821823A2 (es) |
| CA (1) | CA2710794A1 (es) |
| CL (1) | CL2008003929A1 (es) |
| CO (1) | CO6331311A2 (es) |
| EA (1) | EA201070818A1 (es) |
| FR (1) | FR2925904B1 (es) |
| IL (1) | IL206672A0 (es) |
| MA (1) | MA32058B1 (es) |
| MX (1) | MX2010007352A (es) |
| PA (1) | PA8810201A1 (es) |
| PE (1) | PE20091531A1 (es) |
| TW (1) | TW200936133A (es) |
| UY (1) | UY31590A1 (es) |
| WO (1) | WO2009106751A2 (es) |
| ZA (1) | ZA201004646B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2925907B1 (fr) * | 2008-01-02 | 2010-10-15 | Sanofi Aventis | DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| WO2012147890A1 (ja) * | 2011-04-27 | 2012-11-01 | 持田製薬株式会社 | 新規アゾール誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004103991A1 (fr) * | 2003-05-20 | 2004-12-02 | 'chemical Diversity Research Institute', Ltd. | Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique |
| US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| EP1849465A4 (en) * | 2005-02-18 | 2008-12-24 | Takeda Pharmaceutical | AGENT FOR CONTROLLING THE FUNCTION OF THE GPR34 RECEPTOR |
| ES2400287T3 (es) * | 2005-03-14 | 2013-04-08 | High Point Pharmaceuticals, Llc | Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa |
| TW200800997A (en) * | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
-
2008
- 2008-01-02 FR FR0800006A patent/FR2925904B1/fr not_active Expired - Fee Related
- 2008-12-23 PA PA20088810201A patent/PA8810201A1/es unknown
- 2008-12-30 CL CL2008003929A patent/CL2008003929A1/es unknown
- 2008-12-30 PE PE2008002194A patent/PE20091531A1/es not_active Application Discontinuation
- 2008-12-30 AR ARP080105780A patent/AR070075A1/es unknown
- 2008-12-30 UY UY31590A patent/UY31590A1/es not_active Application Discontinuation
- 2008-12-31 JP JP2010541087A patent/JP2011508762A/ja not_active Withdrawn
- 2008-12-31 EP EP08872982A patent/EP2225243B1/fr active Active
- 2008-12-31 WO PCT/FR2008/001838 patent/WO2009106751A2/fr active Application Filing
- 2008-12-31 EA EA201070818A patent/EA201070818A1/ru unknown
- 2008-12-31 MX MX2010007352A patent/MX2010007352A/es active IP Right Grant
- 2008-12-31 CN CN2008801277673A patent/CN101959885A/zh active Pending
- 2008-12-31 AT AT08872982T patent/ATE533767T1/de active
- 2008-12-31 TW TW097151696A patent/TW200936133A/zh unknown
- 2008-12-31 BR BRPI0821823-4A patent/BRPI0821823A2/pt not_active IP Right Cessation
- 2008-12-31 AU AU2008351929A patent/AU2008351929A1/en not_active Abandoned
- 2008-12-31 CA CA2710794A patent/CA2710794A1/fr not_active Abandoned
- 2008-12-31 KR KR1020107017145A patent/KR20100103660A/ko not_active Application Discontinuation
-
2010
- 2010-06-28 IL IL206672A patent/IL206672A0/en unknown
- 2010-07-01 US US12/828,376 patent/US20100317686A1/en not_active Abandoned
- 2010-07-01 ZA ZA2010/04646A patent/ZA201004646B/en unknown
- 2010-07-02 CO CO10080869A patent/CO6331311A2/es not_active Application Discontinuation
- 2010-08-02 MA MA33056A patent/MA32058B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2925904B1 (fr) | 2010-01-01 |
| KR20100103660A (ko) | 2010-09-27 |
| MA32058B1 (fr) | 2011-02-01 |
| EA201070818A1 (ru) | 2011-02-28 |
| ATE533767T1 (de) | 2011-12-15 |
| FR2925904A1 (fr) | 2009-07-03 |
| EP2225243A2 (fr) | 2010-09-08 |
| CN101959885A (zh) | 2011-01-26 |
| ZA201004646B (en) | 2011-09-28 |
| EP2225243B1 (fr) | 2011-11-16 |
| CL2008003929A1 (es) | 2010-01-22 |
| UY31590A1 (es) | 2009-08-03 |
| IL206672A0 (en) | 2010-12-30 |
| MX2010007352A (es) | 2010-08-18 |
| CA2710794A1 (fr) | 2009-09-03 |
| TW200936133A (en) | 2009-09-01 |
| US20100317686A1 (en) | 2010-12-16 |
| WO2009106751A2 (fr) | 2009-09-03 |
| PA8810201A1 (es) | 2009-08-26 |
| WO2009106751A3 (fr) | 2010-02-25 |
| AU2008351929A1 (en) | 2009-09-03 |
| BRPI0821823A2 (pt) | 2015-06-16 |
| AR070075A1 (es) | 2010-03-10 |
| CO6331311A2 (es) | 2011-10-20 |
| JP2011508762A (ja) | 2011-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20120493A1 (es) | Pirimidinonas como inhibidores de pi3k | |
| PE20090049A1 (es) | Derivados de piridopirimidina como moduladores de la actividad de pde 4 | |
| PE20130402A1 (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
| UY31730A (es) | Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica. | |
| BRPI0714320A2 (pt) | Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica | |
| PE20091818A1 (es) | DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| AR064608A1 (es) | Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer. | |
| PE20051094A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico y procesos para su preparacion | |
| PE20040197A1 (es) | Pirazolopiridinas sustituidas con carbamato | |
| MX2018003215A (es) | Derivados de imidazo[4,5-c]quinolina e imidazo[4,5-c][1,5]naftirid ina novedosos como inhibidores de lrrk2. | |
| AR078841A1 (es) | Derivados de imidazo(1,2-b) piridazina y su uso como inhibidores de pde10 | |
| NO20082757L (no) | Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater | |
| PE20091321A1 (es) | Derivados biciclicos de carboxamidas aza-biciclicas, su preparacion y su aplicacion en terapeutica | |
| ATE555786T1 (de) | 1-alkoxy 1h-imidazo-ringsysteme und verfahren | |
| UY31729A (es) | Derivados polisustituidos de 2-heteroaril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapeútica | |
| PE20140970A1 (es) | Derivados de 6-ciclobutil-1,5-dihidro-pirazol [3,4-d) pirimidin-4-ona y su uso como inhibidores de pde9a | |
| MY137609A (en) | Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation | |
| PE20142366A1 (es) | Compuestos triazolo como inhibidores de pde 10 | |
| UY31588A1 (es) | Derivados de imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica | |
| DK2040703T3 (da) | Derivater af 2-benzoylimidazopyridiner, fremstilling deraf og terapeutisk anvendelse deraf | |
| UY31587A1 (es) | Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica. | |
| PE20091531A1 (es) | DERIVADOS DE N-HETEROCICLICO-6-HETEROCICLICO-IMIDAZO[1,2-a]PIRIDINA-2-CARBOXAMIDA COMO MODULADORES DE LOS RECEPTORES NURR-1 | |
| PE20180316A1 (es) | Compuestos piridopirimidinona y su uso como moduladores del receptor de nmda | |
| UA110245C2 (en) | 7-(heleroaryl-amino)-6,7,8,9-letrahydropyrido[1,2-a]indol acetic acid derivatives and their application as prostaglandin d2 receptor modulators | |
| AR070074A1 (es) | Derivados 6- heterociclico- imidazo ( 1,2-alfa) piridina -2- carboxamidas, su preparacion y su aplicacion en terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |